|
This list is published on healthsprocket.com at Source URL: https://healthsprocket.com/hs/content/novartis-ags-top-10-drugs-based-revenue-2017 Visit now to read comments, add your own comments and rate this list. |
Fact Based List:
Novartis AG's top 10 drugs based on revenue in 2017
Submitted By Anonymous, Created 02/23/2018 - 13:02
- Gilenya $3.185 billion
- Cosentyx $2.071 billion
- Gleevec/glivec $1.943 billion
- Lucentis $1.888 billion
- Tasigna $1.841 billion
- Sandostatin $1.612 billion
- Afinitor/Votubia $1.525 billion
- Galvus $1.233 billion
- Exjade $1.059 billion
- Exforge $0.960 billion
Source: Statista
Source URL: https://www.statista.com/statistics/278114/novartis-top-drug...